Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The role of interaction of polymorphisms in the Renin-Angiotensin-System (RAS) with angiotensin converting enzyme (ACE) or angiotensin receptor (AGTR1) inhibitors (RAS inhibitors) is unknown, as is the role of such therapy in end stage renal disease (ESRD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP378328.RAAhQFBunj-ti4CiIkAT-AqTVrNd-AvagdXwY47_HdPMQ130_assertion description "[The role of interaction of polymorphisms in the Renin-Angiotensin-System (RAS) with angiotensin converting enzyme (ACE) or angiotensin receptor (AGTR1) inhibitors (RAS inhibitors) is unknown, as is the role of such therapy in end stage renal disease (ESRD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378328.RAAhQFBunj-ti4CiIkAT-AqTVrNd-AvagdXwY47_HdPMQ130_provenance.
• assertion description "[The role of interaction of polymorphisms in the Renin-Angiotensin-System (RAS) with angiotensin converting enzyme (ACE) or angiotensin receptor (AGTR1) inhibitors (RAS inhibitors) is unknown, as is the role of such therapy in end stage renal disease (ESRD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP670177.RADoKyxpd3WZs8m4Dw0202gPTN2gwdxByaQhvPAT6DnZY130_assertion description "[The role of interaction of polymorphisms in the Renin-Angiotensin-System (RAS) with angiotensin converting enzyme (ACE) or angiotensin receptor (AGTR1) inhibitors (RAS inhibitors) is unknown, as is the role of such therapy in end stage renal disease (ESRD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP670177.RADoKyxpd3WZs8m4Dw0202gPTN2gwdxByaQhvPAT6DnZY130_provenance.
• NP498663.RAXQ3kqTuD-zoym0hBZjpWzqLWnHJTvfhXCTSUiQB6714130_assertion description "[The role of interaction of polymorphisms in the Renin-Angiotensin-System (RAS) with angiotensin converting enzyme (ACE) or angiotensin receptor (AGTR1) inhibitors (RAS inhibitors) is unknown, as is the role of such therapy in end stage renal disease (ESRD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498663.RAXQ3kqTuD-zoym0hBZjpWzqLWnHJTvfhXCTSUiQB6714130_provenance.
• NP498666.RAQ0fFjNkQYR7Ya3xIbJN9FbjwAY4_E2Fw3NU8RVAbKfw130_assertion description "[The role of interaction of polymorphisms in the Renin-Angiotensin-System (RAS) with angiotensin converting enzyme (ACE) or angiotensin receptor (AGTR1) inhibitors (RAS inhibitors) is unknown, as is the role of such therapy in end stage renal disease (ESRD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498666.RAQ0fFjNkQYR7Ya3xIbJN9FbjwAY4_E2Fw3NU8RVAbKfw130_provenance.
• NP498667.RAZmhYgyUEOEZdhxnbUcqPBuSLlECab9wYcbB3GiWDnMs130_assertion description "[The role of interaction of polymorphisms in the Renin-Angiotensin-System (RAS) with angiotensin converting enzyme (ACE) or angiotensin receptor (AGTR1) inhibitors (RAS inhibitors) is unknown, as is the role of such therapy in end stage renal disease (ESRD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498667.RAZmhYgyUEOEZdhxnbUcqPBuSLlECab9wYcbB3GiWDnMs130_provenance.
• NP230422.RAgxdp-wHNrdMjnz1i38vX5N2PYYKBivLC-8zSPIsOxjI130_assertion description "[The role of interaction of polymorphisms in the Renin-Angiotensin-System (RAS) with angiotensin converting enzyme (ACE) or angiotensin receptor (AGTR1) inhibitors (RAS inhibitors) is unknown, as is the role of such therapy in end stage renal disease (ESRD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230422.RAgxdp-wHNrdMjnz1i38vX5N2PYYKBivLC-8zSPIsOxjI130_provenance.
• NP813642.RAP8Kid_YWgYdCWSttxHVj9PVxN3GKmQ7h2-mpyA6t-Hs130_assertion description "[The role of interaction of polymorphisms in the Renin-Angiotensin-System (RAS) with angiotensin converting enzyme (ACE) or angiotensin receptor (AGTR1) inhibitors (RAS inhibitors) is unknown, as is the role of such therapy in end stage renal disease (ESRD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP813642.RAP8Kid_YWgYdCWSttxHVj9PVxN3GKmQ7h2-mpyA6t-Hs130_provenance.
• NP230090.RA9VEjCOdFPgOgZWTjouz_nl2lPbqdZg3nHNLGhZJ92No130_assertion description "[The role of interaction of polymorphisms in the Renin-Angiotensin-System (RAS) with angiotensin converting enzyme (ACE) or angiotensin receptor (AGTR1) inhibitors (RAS inhibitors) is unknown, as is the role of such therapy in end stage renal disease (ESRD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP230090.RA9VEjCOdFPgOgZWTjouz_nl2lPbqdZg3nHNLGhZJ92No130_provenance.
• NP669656.RAyR6G0bTNPrGirTAm9MLs44RivbA69LmBoflFWI7Vsmk130_assertion description "[The role of interaction of polymorphisms in the Renin-Angiotensin-System (RAS) with angiotensin converting enzyme (ACE) or angiotensin receptor (AGTR1) inhibitors (RAS inhibitors) is unknown, as is the role of such therapy in end stage renal disease (ESRD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP669656.RAyR6G0bTNPrGirTAm9MLs44RivbA69LmBoflFWI7Vsmk130_provenance.
• NP498665.RAINpEQ6_O7_BP_EWMjl9aeIKWKFq6Z3DaPGU4R3RCLUg130_assertion description "[The role of interaction of polymorphisms in the Renin-Angiotensin-System (RAS) with angiotensin converting enzyme (ACE) or angiotensin receptor (AGTR1) inhibitors (RAS inhibitors) is unknown, as is the role of such therapy in end stage renal disease (ESRD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498665.RAINpEQ6_O7_BP_EWMjl9aeIKWKFq6Z3DaPGU4R3RCLUg130_provenance.
• NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_assertion description "[The role of interaction of polymorphisms in the Renin-Angiotensin-System (RAS) with angiotensin converting enzyme (ACE) or angiotensin receptor (AGTR1) inhibitors (RAS inhibitors) is unknown, as is the role of such therapy in end stage renal disease (ESRD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498662.RA0oXBVlUMx4br10Q63S_ueuIrM4DB26kHJu5C4hhM_mA130_provenance.
• NP498664.RA1u31Fk_aG05kF78DX38Cssyp2W8wJWzTPXGC5ifqFeE130_assertion description "[The role of interaction of polymorphisms in the Renin-Angiotensin-System (RAS) with angiotensin converting enzyme (ACE) or angiotensin receptor (AGTR1) inhibitors (RAS inhibitors) is unknown, as is the role of such therapy in end stage renal disease (ESRD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498664.RA1u31Fk_aG05kF78DX38Cssyp2W8wJWzTPXGC5ifqFeE130_provenance.